Long-term lamivudine treatment of children with chronic hepatitis B: Durability of therapeutic responses and safety

Journal of Viral Hepatitis

Volumn 15, Issue 1, 2008, Pages 20-27

  Jonas, M M ^a   Little, N R ^b   Gardner, S D ^b   Alonso, E M ^c   Alvarez, F ^d   Areias, J ^e   Badia, I ^f   Cordeiro Ferreira, G ^g   Gremse, D ^h   Haber, B ⁱ   Kelly, D ^j   Manolaki, N ^k   Mizerski, J ^l   Mohan, P ^m   Molleston, J ⁿ   Murray, K ^o   Po I ^p   Porta, G ^q   Rodriguez Baez, N ^r   Schwarz, K ^s   Sokal, E ^t   Sluzewski, W ^u   Woynarowski, M ^v   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF MONTREAL   (Canada)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f Hospital General de Niños   (Argentina)

^g HOSPITAL FERNANDO FONSECA   (Portugal)

^h UNIVERSITY OF SOUTH ALABAMA   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^k AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^l Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^m CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁿ RILEY HOSPITAL FOR CHILDREN   (United States)

^o SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^p HOSPITAL DONA ESTEFÂNIA   (Portugal)

^q Instituto Da Criança Prof Pedro de Alcântara   (Brazil)

^r Children's Medical Center   (United States)

^s JOHNS HOPKINS HOSPITAL   (United States)

^t CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^u Klinica Obserwacyjno Zakazna   (Poland)

^v CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

more..

Author keywords

Adolescent; Child; Hepatitis B; Lamivudine; Treatment

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PLACEBO; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; VIROLOGY;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; RETROSPECTIVE STUDIES;

EID: 36949014058     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00891.x     Document Type: Article

References (13)

1. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997 336 : 247 256.
2. Jonas MM, Kelly DA, Mizerski J et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002 346 : 1706 1713.
3. Sokal EM, Kelly DA, Mizerski J et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006 43 : 225 232.
4. Hom X, Little NR, Gardner SD, Jonas MM. Predictors of virologic response to lamivudine treatment in children with chronic hepatitis B. Pediatr Infect Dis J 2004 23 : 441 445.
5. Liaw Y-F, Leung NWY, Chang T-T et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 2000 119 : 172 180.
6. Lau DT-Y, Khokhar MF, Doo E et al. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 2000 32 : 828 834.
7. Leung NWY, Lai C-L, Chang T-T et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001 33 : 1527 1532.
8. Dienstag JL, Cianciara J, Karayalcin S et al. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology 2003 37 : 748 755.
9. Dienstag JL, Goldin RD, Heathcote EJ et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003 124 (1 105 117.
10. Choe B-H, Lee JY, Jang YC et al. Long-term therapeutic efficacy of lamivudine compared with interferon-α in children with chronic hepatitis B: the younger the better. JPGN 2007 44 : 92 98.
11. Ozgenc F, Arikan C, Sertoz RY et al. Effect of long-term lamivudine in chronic hepatitis B virus-infected children. Antivir Ther 2004 9 : 729 732.
12. Hartman C, Berkowitz D, Eshach-Adiv O et al. Long-term lamivudine therapy for chronic hepatitis B infection in children unresponsive to interferon. J Pediatr Gastro 2006 43 : 494 498.
13. Liaw Y-F, Chien R-N, Yeh C-T. No benefit to continue lamivudine therapy after emergence of YMDD mutations. Antivir Ther 2004 9 : 257 262.